Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more
Clinical Laserthermia Systems AB (publ) (CLS-B) - Total Assets
Latest total assets as of December 2025: Skr76.49 Million SEK
Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) holds total assets worth Skr76.49 Million SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Clinical Laserthermia Systems AB (publ) - Total Assets Trend (2008–2025)
This chart illustrates how Clinical Laserthermia Systems AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Clinical Laserthermia Systems AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
Clinical Laserthermia Systems AB (publ)'s total assets of Skr76.49 Million consist of 51.2% current assets and 48.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 28.2% |
| Accounts Receivable | Skr4.88 Million | 6.4% |
| Inventory | Skr12.70 Million | 16.6% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr11.29 Million | 14.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Clinical Laserthermia Systems AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Clinical Laserthermia Systems AB (publ)'s current assets represent 51.2% of total assets in 2025, an increase from 40.4% in 2008.
- Cash Position: Cash and equivalents constituted 28.2% of total assets in 2025, down from 36.1% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 56.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 16.6% of total assets.
Clinical Laserthermia Systems AB (publ) Competitors by Total Assets
Key competitors of Clinical Laserthermia Systems AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Clinical Laserthermia Systems AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Clinical Laserthermia Systems AB (publ) generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Clinical Laserthermia Systems AB (publ) is currently not profitable relative to its asset base.
Clinical Laserthermia Systems AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.91 | 2.99 | 0.56 |
| Quick Ratio | 2.64 | 2.35 | 0.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr29.12 Million | Skr 25.54 Million | Skr -19.41 Million |
Clinical Laserthermia Systems AB (publ) - Advanced Valuation Insights
This section examines the relationship between Clinical Laserthermia Systems AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.46 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -2.6% |
| Total Assets | Skr76.49 Million |
| Market Capitalization | $13.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Clinical Laserthermia Systems AB (publ)'s assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Clinical Laserthermia Systems AB (publ)'s assets decreased by 2.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below shows the annual total assets of Clinical Laserthermia Systems AB (publ) from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr76.49 Million | -2.64% |
| 2024-12-31 | Skr78.56 Million | +36.10% |
| 2023-12-31 | Skr57.73 Million | +16.60% |
| 2022-12-31 | Skr49.51 Million | -25.82% |
| 2021-12-31 | Skr66.74 Million | +50.31% |
| 2020-12-31 | Skr44.40 Million | +14.82% |
| 2019-12-31 | Skr38.67 Million | -33.36% |
| 2018-12-31 | Skr58.02 Million | +29.11% |
| 2017-12-31 | Skr44.94 Million | +64.59% |
| 2016-12-31 | Skr27.30 Million | +22.62% |
| 2015-12-31 | Skr22.27 Million | -39.74% |
| 2014-12-31 | Skr36.95 Million | +26.56% |
| 2013-12-31 | Skr29.20 Million | +45.54% |
| 2012-12-31 | Skr20.06 Million | +54.26% |
| 2011-12-31 | Skr13.01 Million | +10.56% |
| 2010-12-31 | Skr11.76 Million | +43.41% |
| 2009-12-31 | Skr8.20 Million | +48.50% |
| 2008-12-31 | Skr5.52 Million | -- |